Drug Type siRNA |
Synonyms RBD7007 |
Target |
Action inhibitors |
Mechanism C5 inhibitors(Complement C5 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Disorder of Complement | Phase 1 | China | - | |
| Glomerulonephritis, IGA | Phase 1 | China | - | |
| Hemoglobinuria, Paroxysmal | IND Approval | Sweden | 01 Oct 2024 | |
| Rare Diseases | Discovery | China | - |





